Attention deficit hyperactivity disorder and Weight
Weight is found among people with Attention deficit hyperactivity disorder, especially for people who are male, 10-19 old.
The study analyzes which people have Weight with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 1,335 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,335 people who have Attention Deficit Hyperactivity Disorder and Weight are studied.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 1,526 drugs and 1,247 conditions by eHealthMe.
What is Weight?
Weight is found to be associated with 2,740 drugs and 2,209 conditions by eHealthMe.
Number of Weight in Attention deficit hyperactivity disorder reports submitted per year:
Gender of people who have Attention deficit hyperactivity disorder and experienced Weight *:
Age of people who have Attention deficit hyperactivity disorder and experienced Weight *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weight?Check whether Weight is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (107,095 reports)
- Weight (50,812 reports)
COVID vaccines that are related to Weight:
- Weight in Moderna COVID Vaccine
- Weight in Pfizer BioNTech Covid Vaccine
- Weight in Johnson and Johnson Covid Vaccine
Common drugs associated with Weight:
- Risperdal: 4,515 reports
- Seroquel: 2,223 reports
- Risperidone: 2,094 reports
- Prednisone: 1,985 reports
- Zyprexa: 1,608 reports
- Methotrexate: 1,435 reports
- Metformin: 1,423 reports
- Humira: 1,377 reports
- Aspirin: 1,279 reports
- Abilify: 1,235 reports
All the drugs that are associated with Weight:
- Weight (2,740 drugs)
Common conditions associated with Weight:
- Depression: 2,066 reports
- Bipolar disorder: 1,904 reports
- Schizophrenia: 1,856 reports
- Attention deficit hyperactivity disorder: 1,335 reports
- High blood pressure: 1,334 reports
- Rheumatoid arthritis: 1,226 reports
- Pain: 1,051 reports
All the conditions that are associated with Weight:
- Weight (2,209 conditions)
How the study uses the data?
The study is based on Weight and Attention deficit hyperactivity disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Theophylline and Seizures - a second ago
- Votrient and Silodosin drug interaction - 9 seconds ago
- Loraz and Acinetobacter Infection - 19 seconds ago
- Clobex and Multiple Sclerosis Aggravated - 22 seconds ago
- Escitalopram and Humulin 70/30 drug interaction - 35 seconds ago
- Phoslo and Leukocytoclastic Vasculitis - 38 seconds ago
- Augmentin and Respiratory Arrest (Excl Neonatal) - 40 seconds ago
- Prozac and Itraconazole drug interaction - 49 seconds ago
- Avastin and Xeroderma - 54 seconds ago
- How effective is Gabapentin for Generalized Anxiety Disorder? - a minute ago